SathyaSKrishnasamyMD
Endocrinology • Louisville, KYDiabetes, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology, Thyroid
Professor, Medicine, University of Louisville School of Medicine
Dr. Krishnasamy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 E Chestnut St
Unit 310
Louisville, KY 40202Phone+1 502-588-4600
Summary
- Dr. Sathya Krishnasamy is an academic endocrinologist in Louisville, KY and is affiliated with UofL Health - UofL Hospital. She received her medical degree from Kilpauk Medical College and has been in practice 30 years. She specializes in diabetes ,thyroid diseases, Pituitary diseases, Bone and Calcium disorders and Cystic fibrosis related endocrinopathies.
Education & Training
University of Louisville School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2006
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1994 - 1997
Kilpauk Medical CollegeClass of 1990
Certifications & Licensure
IN State Medical License 1999 - 2025
KY State Medical License 1999 - 2025
IL State Medical License 1994 - 2002- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 4 citationsIllustration of Gut-Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function.Manasa Sagaram, Amor J Royer, Huirong Hu, Abhas Rajhans, Ranganathan Parthasarathy
Cells. 2022-10-01 - 96 citationsAssociation Between Residential Greenness and Cardiovascular Disease Risk.Ray Yeager, Daniel W. Riggs, Natasha DeJarnett, David J. Tollerud, Jeffrey S. Wilson
Journal of the American Heart Association. 2018-12-18 - 45 citationsExposure to volatile organic compounds – acrolein, 1,3-butadiene, and crotonaldehyde – is associated with vascular dysfunctionKatlyn E. McGraw, Daniel W. Riggs, Shesh N. Rai, Ana Navas-Acien, Zhengzhi Xie
Environmental Research. 2021-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
